US Sexually-Transmitted Diseases (STD) Testing Market 2021: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities Table of Contents
US Sexually-Transmitted Diseases (STD) Testing Market 2021: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
About This Report
This new 280-page report from LeadingMarketResearch.com presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.
The report provides test volume and sales projections for Hospitals, Commercial, Physician Offices, and Public Health Labs.
In addition to market share and sales forecasts, the report:
- Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analyzers used for STD testing;
- Profiles key suppliers and potential market entrants developing innovative technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as LeadingMarketResearch’s proprietary data files was conducted.
Contains280 pages and 18 tables.
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.